M.D. Sass LLC’s Cognizant CTSH Stock Holding History

M.D. Sass LLC’s Portfolio CTSH Stock Details CTSH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-24,400	Closed	-$1.77M	–	49
2017 Q3	$1.77M	Sell	24,400 -723,223	-97%	-$50.8M	0.15%	49
2017 Q2	$49.6M	Buy	+747,623	New	+$47.5M	3.25%	14

Other funds holding CTSH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

M.D. Sass LLC's CTSH Position: Q4 2017 in Review

M.D. Sass LLC sold out of Cognizant (CTSH) in Q4 2017, closing a stake of 24,400 shares — an estimated $1.77M sold.

M.D. Sass LLC first reported a position in CTSH in Q2 2017 and held it in 2 quarters. The position peaked at $49.6M in Q2 2017. 1,012 funds tracked by Wall St. Rank hold CTSH as of Q4 2017.

M.D. Sass LLC reported no remaining Cognizant position as of Q4 2017 after selling out during the quarter.
M.D. Sass LLC sold 24,400 Cognizant shares in Q4 2017, an estimated $1.77M.
M.D. Sass LLC first reported a position in Cognizant in Q2 2017 and held it in 2 quarters.
M.D. Sass LLC's Cognizant position peaked at $49.6M in Q2 2017.
1,012 funds tracked by Wall St. Rank held Cognizant as of Q4 2017.

Based on M.D. Sass LLC's 13F filing for Q4 2017, filed 13 Feb 2018.